Leading the way to safer medication
 Crosscheck  Recommender

Agomelatine

Description

Agomelatine is a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist. In humans, agomelatine has positive phase shifting properties; it induces a phase advance of sleep, body temperature decline and melatonin onset.

ATC Classification

Code
Title
Category
N06AX22
Agomelatine
N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants

Trade names

Trade name
Countries

Spain

Austria

Austria Cyprus France Netherlands Singapore

Austria

Trade names (in combination): AGOGEROLAN AGOMELATIN

Product Monographs

Monograph
Type
Country
VALDOXAN Film-coated tablets
MPI, EU: SmPC